首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Predominant expression of beta 1-adrenergic receptor in the thick ascending limb of rat kidney. Absolute mRNA quantitation by reverse transcription and polymerase chain reaction.
【2h】

Predominant expression of beta 1-adrenergic receptor in the thick ascending limb of rat kidney. Absolute mRNA quantitation by reverse transcription and polymerase chain reaction.

机译:β1肾上腺素能受体在大鼠肾脏升粗的上肢中主要表达。通过反转录和聚合酶链反应对mRNA进行绝对定量。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Beta 1- and beta 2-adrenergic receptor (beta-ARs) expression in the thick ascending limb of rat kidney was studied at the level of mRNA and receptor coupling to adenylyl cyclase. Absolute quantitation of beta 1- and beta 2-AR mRNAs in microdissected nephron segments was performed with an assay based on reverse transcription and polymerase chain reaction, using in vitro transcribed mutant RNAs as internal standards. In the cortical thick ascending limb (CTAL), the number of mRNA molecules/mm of tubular length was 2,806 +/- 328 (n = 12) for beta 1-AR and 159 +/- 26 for beta 2-AR (P < 0.01). Lower levels were obtained in the medullary thick ascending, beta 1-AR mRNA still being predominant. The pharmacological properties of beta-ARS was also studied in the CTAL. Cyclic AMP accumulation was stimulated by beta-agonist with a rank order of potency of isoproterenol > norepinephrine > epinephrine. This observation, and the higher efficiency of a beta 1 than of a beta 2 antagonist to inhibit isoproterenol-induced cAMP accumulation, establish the typical beta 1-AR sensitivity of the CTAL. No detectable contribution of atypical or beta 3-ARs to adenylyl cyclase stimulation could be found. In conclusion, this study, which shows markedly different levels of beta 1- and beta 2-AR mRNAS in the CTAL, provides a molecular basis for the predominant expression of the beta 1 receptor subtype in this nephron segment.
机译:研究了在大鼠肾的厚升肢中β1-和β2-肾上腺素能受体(β-ARs)的表达,其表达水平与受体和腺苷酸环化酶偶联。使用体外转录的突变RNA作为内标,使用基于逆转录和聚合酶链反应的测定法,对显微解剖的肾单位中的β1-AR和β2-AR mRNA进行了绝对定量。在皮质增厚肢体(CTAL)中,β1-AR的每毫米管状长度的mRNA分子数为2,806 +/- 328(n = 12),β2-AR的为159 +/- 26(P < 0.01)。在髓质增厚中获得较低的水平,β1-AR mRNA仍占主导地位。在CTAL中还研究了β-ARS的药理特性。 β-激动剂以异丙基肾上腺素>去甲肾上腺素>肾上腺素的效能等级顺序刺激环AMP的积累。这一观察结果以及与β2拮抗剂相比,β1抑制异丙肾上腺素诱导的cAMP积累的效率更高,建立了CTAL的典型β1-AR敏感性。没有发现非典型或β3-AR对腺苷酸环化酶刺激的可检测的贡献。总而言之,这项研究表明CTAL中β1-和β2-AR mRNA的水平明显不同,为该肾单位区段中β1受体亚型的主要表达提供了分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号